<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00837213</url>
  </required_header>
  <id_info>
    <org_study_id>EVF0701</org_study_id>
    <nct_id>NCT00837213</nct_id>
  </id_info>
  <brief_title>Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne</brief_title>
  <official_title>Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stiefel, a GSK Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy and safety of Benzoyl peroxide used in combination with clindamycin
      vs. Benzoyl peroxide used in combination with clindamycin and doxycycline in the treatment of
      moderate acne
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the efficacy and safety of Benzoyl peroxide used in combination with clindamycin
      vs. Benzoyl peroxide used in combination with clindamycin and doxycycline once daily in the
      treatment of moderate acne
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change in Inflammatory Acne Lesions From Baseline to Week 16</measure>
    <time_frame>Baseline, Week 16</time_frame>
    <description>Percent change from baseline to week 16 in inflammatory acne lesions (pustules/papules)(chest and back)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent (%) Change in Non-inflammatory Acne Lesions From Baseline to Week 16.</measure>
    <time_frame>Baseline, Week 16</time_frame>
    <description>Percent change in Non-inflammatory acne lesions (whiteheads and blackheads)(chest and back) from baseline to week 16.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent Change in Total Acne Lesion Counts From Baseline to Week 16</measure>
    <time_frame>Baseline, Week 16</time_frame>
    <description>Percent change from baseline to week 16 in total acne lesions (inflammatory + non-inflammatory)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Investigator Global Assessment (IGA)</measure>
    <time_frame>Baseline, Weeks 4, 8,12, and 16</time_frame>
    <description>Change in Investigator Global Assessment (IGA) Average values chest and back.
IGA scale:
0 - Clear
0.5 - Clear/almost clear
Almost Clear
1.5- Almost Clear/Mild
Mild
2.5- Mild/Moderate
Moderate
3.5- Moderate/Severe</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent (%) Change in Inflammatory Lesion Counts (Chest and Back) From Baseline to Week 12</measure>
    <time_frame>Baseline, Week 12</time_frame>
    <description>Percent change in inflammatory lesion counts (chest and back)from Baseline to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Change in Non-inflammatory Lesions (Chest and Back) From Baseline to Week 12</measure>
    <time_frame>Baseline, Week 12</time_frame>
    <description>Percent change in non-inflammatory lesions (chest and back) from baseline to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Change in Total Lesions (Chest and Back) From Baseline to Week 12</measure>
    <time_frame>Week 12</time_frame>
    <description>Percent change in total lesions (chest and back) from baseline to Week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Particpants With IGA Score at Week 16</measure>
    <time_frame>Baseline, Week 16</time_frame>
    <description>Investigator Global Assessment (IGA) at Week 16 based on the Investigator Global Assessment
IGA:
0 - Clear
0.5 - Clear/almost clear
Almost Clear
1.5- Almost Clear/Mild
Mild
2.5- Mild/Moderate
Moderate
3.5- Moderate/Severe</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Acne</condition>
  <arm_group>
    <arm_group_label>BPO with clindamycin foam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Benzoyl peroxide (BPO) wash with clindamycin foam</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BPO + clindamycin foam + doxycycline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Benzoyl peroxide (BPO) wash with clindamycin foam and doxycycline capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzoyl peroxide with clindamycin</intervention_name>
    <description>Benzoyl peroxide wash - Clindamycin foam</description>
    <arm_group_label>BPO with clindamycin foam</arm_group_label>
    <other_name>Acne</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzoyl peroxide with clindamycin and doxycycline</intervention_name>
    <description>Benzoyl peroxide wash - Clindamycin foam - Doxycycline capsules</description>
    <arm_group_label>BPO + clindamycin foam + doxycycline</arm_group_label>
    <other_name>Acne</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects with acne vulgaris . Able to understand the requirements of
             the study and sign informed consent/HIPAA authorization forms.

        Exclusion Criteria:

          -  Known hypersensitivity to any of the components of the study drugs or used of
             prohibited medications or any medical condition that contraindicate the subject's
             participation in the clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Dermatology, Cosmetic and Laser Surgery</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Las Vegas Skin &amp; Cancer Clinic</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2009</study_first_submitted>
  <study_first_submitted_qc>February 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2009</study_first_posted>
  <results_first_submitted>April 7, 2010</results_first_submitted>
  <results_first_submitted_qc>August 6, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 31, 2010</results_first_posted>
  <last_update_submitted>May 24, 2017</last_update_submitted>
  <last_update_submitted_qc>May 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acne</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Doxycycline</mesh_term>
    <mesh_term>Clindamycin</mesh_term>
    <mesh_term>Clindamycin palmitate</mesh_term>
    <mesh_term>Clindamycin phosphate</mesh_term>
    <mesh_term>Benzoyl Peroxide</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period: First Subject Enrolled May 2008, Last Subject completed August 28, 2008.
Types of location: Dermatology Research Center</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
          <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
        </group>
        <group group_id="P2">
          <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
          <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>not stated</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
          <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
        </group>
        <group group_id="B2">
          <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
          <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.9" spread="8.5"/>
                    <measurement group_id="B2" value="21.9" spread="6.9"/>
                    <measurement group_id="B3" value="22.9" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Inflammatory Acne Lesions From Baseline to Week 16</title>
        <description>Percent change from baseline to week 16 in inflammatory acne lesions (pustules/papules)(chest and back)</description>
        <time_frame>Baseline, Week 16</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Inflammatory Acne Lesions From Baseline to Week 16</title>
          <description>Percent change from baseline to week 16 in inflammatory acne lesions (pustules/papules)(chest and back)</description>
          <population>ITT</population>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-52.70" spread="26.83"/>
                    <measurement group_id="O2" value="-48.84" spread="40.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent (%) Change in Non-inflammatory Acne Lesions From Baseline to Week 16.</title>
        <description>Percent change in Non-inflammatory acne lesions (whiteheads and blackheads)(chest and back) from baseline to week 16.</description>
        <time_frame>Baseline, Week 16</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent (%) Change in Non-inflammatory Acne Lesions From Baseline to Week 16.</title>
          <description>Percent change in Non-inflammatory acne lesions (whiteheads and blackheads)(chest and back) from baseline to week 16.</description>
          <population>ITT</population>
          <units>Percent Change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-25.27" spread="45.64"/>
                    <measurement group_id="O2" value="-44.69" spread="43.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent Change in Total Acne Lesion Counts From Baseline to Week 16</title>
        <description>Percent change from baseline to week 16 in total acne lesions (inflammatory + non-inflammatory)</description>
        <time_frame>Baseline, Week 16</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Total Acne Lesion Counts From Baseline to Week 16</title>
          <description>Percent change from baseline to week 16 in total acne lesions (inflammatory + non-inflammatory)</description>
          <population>ITT</population>
          <units>Percent Change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-38.49" spread="33.06"/>
                    <measurement group_id="O2" value="-46.11" spread="39.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent (%) Change in Inflammatory Lesion Counts (Chest and Back) From Baseline to Week 12</title>
        <description>Percent change in inflammatory lesion counts (chest and back)from Baseline to Week 12</description>
        <time_frame>Baseline, Week 12</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent (%) Change in Inflammatory Lesion Counts (Chest and Back) From Baseline to Week 12</title>
          <description>Percent change in inflammatory lesion counts (chest and back)from Baseline to Week 12</description>
          <population>ITT</population>
          <units>Percent Change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-49.04" spread="31.63"/>
                    <measurement group_id="O2" value="-45.44" spread="46.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change in Non-inflammatory Lesions (Chest and Back) From Baseline to Week 12</title>
        <description>Percent change in non-inflammatory lesions (chest and back) from baseline to Week 12</description>
        <time_frame>Baseline, Week 12</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Non-inflammatory Lesions (Chest and Back) From Baseline to Week 12</title>
          <description>Percent change in non-inflammatory lesions (chest and back) from baseline to Week 12</description>
          <population>ITT</population>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-38.43" spread="39.75"/>
                    <measurement group_id="O2" value="-38.52" spread="39.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change in Total Lesions (Chest and Back) From Baseline to Week 12</title>
        <description>Percent change in total lesions (chest and back) from baseline to Week 12</description>
        <time_frame>Week 12</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Total Lesions (Chest and Back) From Baseline to Week 12</title>
          <description>Percent change in total lesions (chest and back) from baseline to Week 12</description>
          <population>ITT</population>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-44.16" spread="29.41"/>
                    <measurement group_id="O2" value="-41.74" spread="38.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Investigator Global Assessment (IGA)</title>
        <description>Change in Investigator Global Assessment (IGA) Average values chest and back.
IGA scale:
0 - Clear
0.5 - Clear/almost clear
Almost Clear
1.5- Almost Clear/Mild
Mild
2.5- Mild/Moderate
Moderate
3.5- Moderate/Severe</description>
        <time_frame>Baseline, Weeks 4, 8,12, and 16</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Investigator Global Assessment (IGA)</title>
          <description>Change in Investigator Global Assessment (IGA) Average values chest and back.
IGA scale:
0 - Clear
0.5 - Clear/almost clear
Almost Clear
1.5- Almost Clear/Mild
Mild
2.5- Mild/Moderate
Moderate
3.5- Moderate/Severe</description>
          <population>ITT</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from Baseline to Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.42" spread="0.57"/>
                    <measurement group_id="O2" value="-0.61" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.55" spread="0.88"/>
                    <measurement group_id="O2" value="-0.85" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" spread="1.07"/>
                    <measurement group_id="O2" value="-1.09" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to Week 16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="0.94"/>
                    <measurement group_id="O2" value="-1.25" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Particpants With IGA Score at Week 16</title>
        <description>Investigator Global Assessment (IGA) at Week 16 based on the Investigator Global Assessment
IGA:
0 - Clear
0.5 - Clear/almost clear
Almost Clear
1.5- Almost Clear/Mild
Mild
2.5- Mild/Moderate
Moderate
3.5- Moderate/Severe</description>
        <time_frame>Baseline, Week 16</time_frame>
        <population>Subjects who completed week 16</population>
        <group_list>
          <group group_id="O1">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
            <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Particpants With IGA Score at Week 16</title>
          <description>Investigator Global Assessment (IGA) at Week 16 based on the Investigator Global Assessment
IGA:
0 - Clear
0.5 - Clear/almost clear
Almost Clear
1.5- Almost Clear/Mild
Mild
2.5- Mild/Moderate
Moderate
3.5- Moderate/Severe</description>
          <population>Subjects who completed week 16</population>
          <units>Percent of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>% Clear skin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% Clear or Almost Clear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% Almost Clear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% Almost clear/ mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% Mild/ Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>16 weeks</time_frame>
      <desc>Subjects who had visits at the first visit (Week 4) after baseline had AEs recorded.</desc>
      <group_list>
        <group group_id="E1">
          <title>Benzoyl Peroxide Wash -Clindamycin Foam</title>
          <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily.</description>
        </group>
        <group group_id="E2">
          <title>Benzoyl Peroxide Wash -Clindamycin Foam -Doxycycline Capsules</title>
          <description>Benzoyl peroxide wash applied in the shower or bath daily with Clindamycin foam applied after the shower or bath daily. Doxycycline 100 mg capsules were taken once a day.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>not used</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Stomach flu</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Cold/ Cold symptoms</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="13"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Nausea/ vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small sample size did not provide adequate power. Even with the limited sample size, total lesion counts provides a more reliable view of the study data due to the greater number of lesions to work with.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>GSK Response Center</name_or_title>
      <organization>GlaxoSmithKline</organization>
      <phone>866-435-7343</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

